Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Propiverine

Drug Profile

Propiverine

Alternative Names: BUP 4; Detrunorm; Detrunorm XL; Mictonet; Mictonetten; Mictonorm; Mictonorm Uno; Mictonorm XL; Mictoryl; Mictoryl Pediatric; P4; Propinorm; Propiverine hydrochloride

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Apogepha
  • Developer Amdipharm; Apogepha; Duchesnay Inc; Otsuka Holdings; sigma-tau SpA; UCB Japan
  • Class Antispasmodics; Benzilates; Small molecules; Urologics
  • Mechanism of Action Calcium channel antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Overactive bladder; Urinary incontinence

Most Recent Events

  • 19 Jun 2020 Propiverine licensed to Consilient Health in Benelux
  • 31 Aug 2017 Launched for Overactive bladder (In children, In adults) in Belgium (PO)
  • 09 May 2017 Launched for Overactive bladder (In adults) in Canada (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top